TCIM
DRNA
TIAA CREF Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.41M | Sell |
96,414
-731
| -0.8% | -$10.7K | ﹤0.01% | 2162 |
|
|
2018
Q4 | $1.04M | Buy |
97,145
+9,429
| +11% | +$101K | ﹤0.01% | 2267 |
|
|
2018
Q3 | $1.34M | Sell |
87,716
-10,947
| -11% | -$167K | ﹤0.01% | 2316 |
|
|
2018
Q2 | $1.21M | Buy |
+98,663
| New | +$1.21M | ﹤0.01% | 2410 |
|
|
2016
Q2 | – | Sell |
-53,105
| Closed | -$285K | – | 3212 |
|
|
2016
Q1 | $285K | Sell |
53,105
-24,542
| -32% | -$132K | ﹤0.01% | 2923 |
|
|
2015
Q4 | $922K | Sell |
77,647
-10,480
| -12% | -$124K | ﹤0.01% | 2627 |
|
|
2015
Q3 | $724K | Buy |
88,127
+27,966
| +46% | +$230K | ﹤0.01% | 2752 |
|
|
2015
Q2 | $839K | Buy |
60,161
+29,057
| +93% | +$405K | ﹤0.01% | 2779 |
|
|
2015
Q1 | $747K | Buy |
31,104
+1,652
| +6% | +$39.7K | ﹤0.01% | 2775 |
|
|
2014
Q4 | $485K | Sell |
29,452
-2,042
| -6% | -$33.6K | ﹤0.01% | 2974 |
|
|
2014
Q3 | $401K | Buy |
31,494
+957
| +3% | +$12.2K | ﹤0.01% | 3018 |
|
|
2014
Q2 | $689K | Buy |
30,537
+19,088
| +167% | +$431K | ﹤0.01% | 2919 |
|
|
2014
Q1 | $323K | Buy |
+11,449
| New | +$323K | ﹤0.01% | 3036 |
|